COSYNE

Serial Number 97976494
Registration 7220288
700

Registration Progress

Application Filed
May 20, 2022
Under Examination
Jul 4, 2023
Approved for Publication
May 9, 2023
Published for Opposition
May 9, 2023
Registered
Nov 14, 2023

Trademark Image

COSYNE

Basic Information

Serial Number
97976494
Registration Number
7220288
Filing Date
May 20, 2022
Registration Date
November 14, 2023
Published for Opposition
May 9, 2023
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 14, 2023
Registration
Registered
Classes
042

Rights Holder

CoSyne Therapeutics Limited

03
Address
WeWork Medius House
2 Sheraton Street
London WIF8BH
GB

Ownership History

CoSyne Therapeutics Limited

Original Applicant
03
London GB

CoSyne Therapeutics Limited

Owner at Publication
03
London GB

CoSyne Therapeutics Limited

Original Registrant
03
London GB

Legal Representation

Attorney
NIGAMNARAYAN ACHARYA

USPTO Deadlines

Next Deadline
1570 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-11-14)
Due Date
November 14, 2029
Grace Period Ends
May 14, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Nov 14, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 14, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Oct 10, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Oct 9, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Sep 19, 2023 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Sep 19, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Aug 26, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 21, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 21, 2023 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Aug 21, 2023 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Aug 21, 2023 IUAF S USE AMENDMENT FILED Loading...
Jul 4, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 9, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 9, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 19, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 31, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 30, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 29, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 29, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 10, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 10, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 10, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 9, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
May 25, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 24, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Drug discovery services; Scientific research for medical purposes in the fields of neuroscience, genetics and computational analysis, and cancer; research and development of pharmaceuticals for the treatment of neurological diseases and cancer; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development; medical research; pharmaceutical testing, pre-clinical research, clinical research, and clinical trials for pharmaceutical product development
First Use Anywhere: Jan 1, 2023
First Use in Commerce: Jan 1, 2023

Additional Information

Pseudo Mark
COSINE

Classification

International Classes
042